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Abstract
Recent innovations in stem cell tech-
nologies and the availability of human
induced pluripotent stem cell-derived car-
diomyocytes (hiPSC-CMs) have opened new
possibilities for studies and drug testing on
human cardiomyocytes in vitro. Still, there
are concerns about the precise nature of such
‘reprogrammed’ cells. We have performed an
investigation using immunocytochemistry
and confocal microscopy on several cellular
features using commercially available
hiPSC-CMs. For some selected developmen-
tally regulated or cardiac chamber-specific
proteins, we have compared the results from
hiPSC-derived cardiomyocytes with freshly
isolated, ventricular cardiomyocytes from
adult rats. The results show that all typical
cardiac proteins are expressed in these
hiPSC-CMs. Furthermore, intercalated disc-
like structures, calcium cycling proteins, and
myofibrils are present. However, some of
these proteins are only known from early
developmental stages of the ventricular
myocardium or the diseased adult heart. A
heterogeneous expression pattern in the cell
population was noted for some muscle pro-
teins, such as for myosin light chains, or
incomplete organization in sarcomeres, such
as for telethonin. These observations indicate
that hiPSC-CMs can be considered genuine
human cardiomyocytes of an early develop-
mental state. The here described marker pro-
teins of maturation may become instrumental
in future studies attempting the improvement
of cardiomyocyte in vitro models. 
Introduction
There is a demand in the life sciences
for a constant supply of highly differentiat-
ed cell types such as cardiomyocytes, hepa-
tocytes, endothelial cells, and neuronal cells
that often show a limited life span, minimal
proliferation capacity, and rapid de-differ-
entiation in primary cell culture. For pri-
mary human cardiomyocytes, there is prac-
tically no supply since healthy organs are
rarely available and the cells quickly expire
without perfusion. Embryonic stem cells
(ESC) originating from the blastocyst stage
of early human embryos raise ethical ques-
tions and cannot be obtained from the same
patient for cell therapies. The few immortal-
ized cardiomyocyte cell lines that are com-
mercially available are of animal origin and
provide little advantage over primary car-
diomyocytes from neonatal rodents.
However, since the first publication in 2006
with murine and 2007 with human cells by
Yamanaka et al.,1 so-called induced
pluripotent stem cells (iPSC) have rapidly
become a popular tool. Cells differentiated
from iPSC appear as a valid alternative to
primary cells for laboratory studies, drug
development, and regenerative medicine. In
the last few years, there have been consider-
able advances in the methods of ‘re-pro-
gramming’ somatic cells to iPSCs using
non-viral transfection and genome editing.2
Subsequently, these cells can be used to
produce differentiated human cell types
such as cardiomyocytes (hiPSC-CMs) using
established protocols.3,4 Existing applica-
tions of hiPSC-CMs include drug safety
testing, disease modeling, and tissue engi-
neering.2,5 With this method, it is possible to
obtain cells from adult patients with cardiac
disorders, with a well-documented disease
and family history, to study the resulting
cellular phenotype in detail. Additionally,
hiPSC-derived cell types can be genetically
modified, for example, to test a gene thera-
py approach in vitro demonstrating the
attempted rescue in a relevant genetic set-
ting. A remaining concern with hiPSC-CMs
is their reportedly immature developmental
status and diverse phenotypes.6,7
We have investigated several cellular
features in commercially available hiPSC-
CMs by immunocytochemistry and confo-
cal microscopy to characterize this type of
model system for future use in toxicology
and basic research. For some selected pro-
teins, we have compared expression and
organization with freshly isolated, adult car-
diomyocytes. This study provides a ‘snap-
shot’ of several cytoskeleton proteins of this
cell type in culture. We did not attempt to
improve maturation of the cells outside of
culturing for ten days to replicate a typical
experimental situation where the non-pro-
liferating cells are used from frozen stock,
treated with test compounds, and analyzed.
Materials and Methods
Cell culture 
Human iPSC-derived cardiomyocytes
(hiPSC-CMs, ax2505) were obtained from
Axol Bioscience (Little Chesterford,
Cambridge, UK). The original hiPSC cell
line was produced using an episomal vector
and CD34+ cord blood cells from a male
newborn donor. Cryopreserved cardiomy-
ocytes were rapidly thawed, then diluted in
maintenance medium with supplements
(Axol Bioscience, ax2530) and 10% fetal
bovine serum. The cells were then seeded
into dishes with a glass-bottom well of 10
mm diameter (MatTek, Ashland, MA, USA)
coated with 1% gelatin in water (Sigma-
Aldrich, St. Louis, MO, USA; G1393).
After 48 h, plating medium was exchanged
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with maintenance medium without serum
for the first time, and then changed every
two days. 
Immunocytochemistry of cultured
cells and confocal microscopy
Cells cultured for 10 days on glass-bot-
tom dishes (MatTek) were washed with
phosphate buffered saline (PBS) then fixed
with 3% para-formaldehyde in PBS for 15
min, permeabilized with 0.2% Triton-X100
(Sigma-Aldrich) in PBS for 10 min, incubat-
ed for 30 min with bovine serum albumin
(Sigma-Aldrich) 1 mg/mL in PBS at room
temperature, incubated overnight with pri-
mary antibodies at 4°C, washed 3 times with
PBS and incubated for 1 h with secondary
antibodies goat anti-rabbit or goat anti-
mouse coupled to AlexaFluor488 or
AlexaFluor546 fluorescent dyes
(Thermofisher Scientific/Molecular Probes,
Waltham, MA, USA) at room temperature in
the dark. Primary antibodies used in this
study are listed in Table 1. Antibodies to
embryonic heart myomesin (EH-myomesin)
and M-protein were a kind gift from Dr. Irina
Agarkova (Federal Institute of Technology,
ETHZ, Zurich, Switzerland). Preparations
were embedded using non-hardening solu-
tions with anti-fading protection with or
without DAPI (SlowFade Diamond,
Invitrogen, Carlsbad, CA, USA; or
Vectashield/DAPI, Vector Laboratories,
Burlingame, CA, USA). Preparations were
examined with a Zeiss LSM 710 confocal
microscope using EC Plan-Neofluar
40x/1.30 and Plan-Apochromat 60x/1.40 oil
immersion lenses (Carl Zeiss, Oberkochen,
Germany). Manual counting of the respec-
tive fraction of cells showing protein expres-
sion and sarcomeric organization was con-
ducted using at least 200 cells from multiple
fields of confocal images from 3 independent
immunocytochemistry experiments and dif-
ferent batches of hiPSC-CMs. Measurement
of morphologic features was performed
using the software NIH-ImageJ (U.S.
National Institutes of Health and available on
the Internet at http://rsb. info.nih.gov/nih-
image/) on confocal images obtained from
cardiomyocytes immunostained for the sar-
comeric M-line marker myomesin. A line-
profile was created along the myofibril and
distances between peaks were measured.
Only cells at resting length were evaluated.
For the form factor, maximum lengths and
widths of cells in low-density cultures were
measured and expressed as a ratio. At least
ten images showing several cells were used
for the analysis of each feature and the data
were statistically analyzed using the two-
tailed Student’s -test (Graphpad Prism). 
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Figure 1. Cytoskeleton and sarcomeric proteins. Overlay images including DAPI are
shown on the left, followed by corresponding green and red channel images in greyscale.
A) Cells were immunostained for alpha-MHC (green), beta-MHC (red) and DNA (blue).
B) Cells were immunostained for MLC2v (green), MLC2a (red) and DNA (blue). Cells
expressing both isoforms appear in orange-yellow. C) Cells were immunostained for
vimentin (green), myomesin (red) and DNA (blue). D) Cells were immunostained for
alpha-tubulin (green), sarcomeric alpha-actinin (red) and DNA (blue). E) Cells were
immunostained for myomesin (green), laminin (red) and DNA (blue).
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Isolation of adult rat cardiomy-
ocytes and immunocytochemistry
Adult rat ventricular cardiomyocytes
(ARVM) were isolated as previously
described8,9 from 3 months old (350-400 g)
male Wistar rats, seeded onto gelatine-coat-
ed chamber slides and immediately fixed
with 4% p-formaldehyde in PBS for 20
minutes. The preparations were permeabi-
lized with 1% Triton-X100 (Sigma-Aldrich)
in PBS for 20 min, incubated for 1 h with
bovine serum albumin (Sigma-Aldrich) 1
mg/mL in PBS at room temperature, incu-
bated overnight with primary antibodies at
4°C, washed 3 times with PBS and incubat-
ed 2 h with secondary antibodies coupled to
Alexa fluorescent dyes (Thermofisher/
Molecular Probes) at room temperature.
Preparations were then washed, embedded
and examined as described for the hiPSC-
CMs. Only primary antibodies equally rec-
ognizing both human and rodent protein
isoforms were selected for this experiment.
All experiments were carried out according
to the Swiss animal protection law and with
the permission of the canton Bern veteri-
nary office (license BE32/14). This investi-
gation conforms to the Guide for the Care
and Use of Laboratory Animals published
by the US National Institutes of Health
(NIH Publication No. 85-23, revised 1996).
Results
Cytoskeleton and sarcomeric proteins
Cryopreserved hiPSC-CMs were
thawed and cultured for ten days as
described in the materials and methods sec-
tion. The cells were then fixed and
immunostained for several cytoskeleton and
sarcomeric proteins (Figure 1). In several
co-stainings, a well-described marker of the
sarcomeric M-line, myomesin,10,11 served to
demonstrate cellular identity and myofibril-
lar content in the cultured cells (Figure 1
C2, E1 and Figure 2 C2,D2,E2). Essential
muscle proteins comprise the family of
myosin heavy chains. Their increase in
expression has been used as a cardiogenic
marker in early embryonic development.12
Immunolabeling of alpha- or beta-myosin
heavy chain proteins resulted in a nearly
identical pattern that only slightly varied in
intensity between cells (Figure 1A). The
myosin heavy chain isoforms were also
found in the freshly isolated ARVM (Figure
3F). Two myosin light chain isoforms have
been described as ventricular and atrial-spe-
cific proteins in the adult heart (MLC2v,
MLC2a).13 We have found hiPSC-CMs
expressing either one of these myosin light
chain isoforms or both, to a different extent
in the cultures (Figures 1B and 4A). As
demonstrated by the immunostaining of
freshly isolated cells from adult rats, the
atrial-specific isoform MLC2a does not
occur in ARVM (Figure 3A). Desmin, the
predominant intermediate filament protein
in striated muscle, has previously been
demonstrated in hiPSC-CMs and ARVM in
our lab.14,15 Vimentin is an intermediate fil-
ament protein that is expressed in fetal car-
diomyocytes and in non-myocytes in adult
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Table 1. Antibodies used in this study.
Target protein                                                        Host                  Vendor, clone, article number
All actin                                                                                          Rabbit                     Sigma-Aldrich, A2066
Alpha smooth muscle actin (ACTA2)                                      Mouse                    Abcam (Cambridge, UK), clone 1A4, ab7817
Alpha-myosin heavy chain (MYH6)                                         Rabbit                     LifeSpan BioSciences (Seattle, WA, USA), LS-C411049
Alpha-tubulin                                                                                Rabbit                     GeneTex (Irvine, CA, USA), GTX112141
Beta-catenin                                                                                 Mouse                    Affymetrix eBiosciences (Santa Clara, CA, USA), clone 15B8, 14-2567-80 
Beta-myosin heavy chain (MYH7)                                           Mouse                    LifeSpan BioSciences, clone IML-64, LS-C312448
BIN-1/amphiphysin-2                                                                  Mouse                    Santa Cruz Biotechnology (Dallas, TX, USA), clone 2F11, sc-23918
Cardiac ankyrin repeat protein (CARP, ANKRD1)                Mouse                    Santa Cruz Biotechnology, clone G2, sc-365056 
Cardiac troponin-I (cTnI, TNNI3)                                           Mouse                    Thermofisher, clone 4C2, MA1-20116
Cardiac troponin-T (cTnT, TNNT2)                                         Mouse                    Thermofisher, clone 13-11, MA5-12960
Connexin-43 (GJA1)                                                                   Rabbit                     Abcam, ab11370 
Desmin                                                                                          Mouse                    LifeSpan BioSciences, LS-B3122-50 
Desmoglein-2                                                                               Mouse                    Abcam, clone 3G132, ab14415
Embryonic-heart myomesin (EH-myomesin)                      Rabbit                     Received as gift28,29
Junctophilin-2                                                                              Mouse                    Santa Cruz Biotechnology, clone H-3, sc-377086
Laminin                                                                                          Rabbit                     Sigma-Aldrich, L9393
M-protein                                                                                      Mouse                    clone AA259, received as gift29,30
Myomesin (all isoforms)                                                          Mouse                    Developmental Studies Hybridoma Bank, University of Iowa, clone B411
Myosin light chain 2v (MLC2v)                                                 Rabbit                     Synaptic Systems (Göttingen, Germany), 310203
Myosin light chain-2a (MLC2a)                                                Mouse                    Synaptic Systems, clone 56F5, 311011
N-cadherin                                                                                    Rabbit                     Santa Cruz Biotechnology, sc-7939
Ryanodine receptor                                                                    Mouse                    Santa Cruz Biotechnology, clone F-1, sc-376507
Sarcomeric alpha-actinin                                                          Mouse                    Abcam, clone EA-53
SERCA2a                                                                                        Mouse                    Abcam, clone 2A7-A1, ab2861
Telethonin/titin cap protein (T cap)                                       Mouse                    Santa Cruz Biotechnology, clone G11, sc-25327
Vimentin                                                                                        Rabbit                     Novus Bio (Littleton, CO, USA) / Bio-techne (Minneapolis, MN, USA), NBP1-31327
tissue and was reported to disappear from
cardiomyocytes postnatally.16 Here we have
stained the cells for vimentin, and for
myomesin to identify cardiomyocytes
(Figure 1C). Vimentin-positive filaments
were found in virtually all hiPSC-CMs in
the culture, but not in freshly isolated
ARVM (Figure 3C). In contrast to vimentin,
desmin was observed only in a fraction of
the cultured cells (not shown, for quantifica-
tion see Figure 4A). The Z-line marker pro-
tein sarcomeric alpha-actinin was found in
all hiPSC-CMs and was organized in sar-
comeres (Figure 1D). Microtubules were
observed in all hiPSC-CMs in culture
(Figure 1D). The distribution pattern of
microtubules was not correlated with other
cytoskeleton elements as previously
observed in cultured adult rat cardiomy-
ocytes.17
Cell-cell contact proteins 
We observed prominent labeling of
adherens junction, desmosomal and gap
junction proteins at cell-cell contacts in the
cultured hiPSC-CMs (Figure 2 A,B). Beta-
catenin-positive junctions occurred at all
cell-cell contacts in the monolayer culture
(Figure 2A). Connexin-43 was found in the
form of gap junction plaques and a perinu-
clear distribution, as has previously been
observed in other cardiomyocyte in vitro
models.18 Junctions positive for N-cadherin
were found at cell-cell contacts partially
colocalizing with desmoglein-2, a typical
marker of desmosomes19 (Figure 2B).
Immunostaining freshly isolated ARVM for
N-cadherin demonstrated the strictly polar-
ized localization of adherens junctions at
the ends of the rod-shaped cells, the interca-
lated discs (Figure 3G). We also investigat-
ed proteins of the so-called costamer com-
plex that provides mechanical anchorage
linking Z-discs of sarcomeres via integrins
to laminin and other extracellular matrix
proteins along the long axis of the cells in
tissue.20 In the cultured hiPSC-CMs,
laminin was found to enclose cultured car-
diomyocytes (Figure 1E), but no striated
pattern along Z-discs was observed as it is
present in the freshly isolated cardiomy-
ocytes immunostained for laminin (Figure
3H).
Calcium-handling proteins
Calcium-handling proteins are part of
the excitation-contraction machinery of car-
diomyocytes and are therefore of great
interest for disease models and drug screen-
ing. Labeling of bridging integrator-1 (bin-
1), a membrane scaffolding protein that is
essential for the formation of T-tubules and
their efficient function,21 showed bin 1 pos-
itive ladders and striation along myofibrils
(Figure 2C). Immunostaining of hiPSC-
CMs for sarcoplasmic reticulum ATPase2a
(SERCA2a) showed labeling in virtually all
cells, although a striated pattern of the stain-
ing was mainly visible in elongated features
with linear myofibrils (Figure 2D).
Immunolabeling for ryanodine receptors
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Figure 2. Junctional proteins and proteins involved in calcium handling. Overlay images
including DAPI are shown on the left, followed by corresponding green and red channel
images in greyscale. A) Cells were immunostained for beta-catenin (green), connexin-43
(red) and DNA (blue). B) Cells were immunostained for N-cadherin (green), desmoglein-
2 (red) and DNA (blue). C) Cells were immunostained for BIN-1/amphiphysin-2 (green)
and EH-myomesin (red). D) Cells were immunostained for SERCA-2a (green), EH-
myomesin (red) and DNA (blue). E) Cells were immunostained for ryanodine receptors
(green), EH-myomesin (red) and DNA (blue). 
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(RyR) showed the protein in all cells,
although the level of organization differed
in the cell population (Figure 2E). The
immunostaining of freshly isolated ARVM
for junctophilin-2, a protein that is essential
for the structural organization of the above
mentioned sarcoplasmic reticulum/ryan-
odine-complex of calcium-handling pro-
teins,22 showed a striated pattern along the
long axis of the cells (Figure 3H).
Developmentally regulated proteins
In the following, we report about sar-
comeric proteins that are known to undergo
an isoform switch from fetal to the adult
human myocardium or to show increasing
levels of structural organization during
development of the heart. We have investi-
gated immunolabeled hiPSC-CMs (Figure
5) and performed counting of the observed
phenotypes (Figure 4A). Telethonin (also
known as T-cap) was described as a signal-
ing and mechano-sensitive element in the
heart.23,24 We have found a generally intense
telethonin labeling of hiPSC-CMs in the 10-
day old culture, although a sarcomeric stri-
ation pattern in the telethonin-channel was
only visible in few places (Figures 4A and
5A) that included myofibrils as demonstrat-
ed by the actin (Figure 5 A2) or myomesin
labeling (Figure 1B). Cardiac ankyrin
repeat protein (CARP) (also known as car-
diac-adriamycin-responsive protein or
ankyrin repeat domain-1, ANKRD1) was
found in the culture and showed a striation
pattern in a sub-population (Figures 4A and
5B). Additionally, a nuclear localization of
CARP in hiPSC-CMs has been noted
(Figure 5 B1), as it has been described pre-
viously in primary cardiomyocytes.25,26 In
the freshly isolated adult cardiomyocytes,
CARP was observed in all cells showing a
distinct I-band striation pattern (Figure 3D).
Troponin-I isoforms have been reported to
represent good markers for cardiomyocyte
maturation because of the switch that
occurs during development from the fetal
form of slow skeletal TnI to the adult car-
diac TnI.27 We have used an antibody for the
adult cardiac troponin-I isoform (Table 1)
and found a patchy expression in the
hiPSC-CM culture (Figures 4A and 5C).
That image shows a group of cells positive
for troponin-I, but also at least one car-
diomyocyte in the lower part of the image,
that does not show any apparent labeling
(Figure 5 C1). Cardiac troponin-T was
found in all hiPSC-CMs in sarcomeric
organization (not shown). Some sarcomeric
and cytoskeleton proteins have been
observed to re-appear in diseases of the
adult heart as part of an adaptation and
remodeling process of the myocardium. An
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Figure 3. Freshly isolated ARVM were immediately fixed and immunostained for the
indicated proteins. A-H) Overlay images of single optical sections are shown in color,
some including DAPI staining for DNA in blue, followed by separate images in greyscale
with the green channel in the middle and red channel on the right.
example for this type of proteins is alpha-
smooth muscle actin, that is only expressed
in smooth muscle cells of the vasculature in
the normal adult heart, but is found in the
myocardium in patients with pathological
cardiac hypertrophy.28 In the hiPSC-CMS
we found a patchy distribution of cells
expressing alpha-smooth muscle actin
(Figures 4A and 5D). Cardiomyocytes were
identified by sarcomeric striation in the all-
actin image (Figure 5 D2). 
Freshly isolated ventricular rat car-
diomyocytes 
Freshly isolated ventricular cardiomy-
ocytes (ARVM) from healthy adult rats pro-
vide bona fide examples for the fully differ-
entiated endpoint of cytoskeleton and sar-
comeric development in the mammalian
heart. We have used ARVM for immunocy-
tochemistry of selected proteins that had
been previously investigated in the cultured
hiPSC-CMs (Figure 3). The same antibod-
ies were used as for the hiPSC-CMs.
Generally, immunolabeling was uniform in
the population of isolated ARVM unlike the
patchy, cell-autonomous distribution seen
for some proteins in the cultured hiPSC-
CMs. The results confirmed the specificity
of the myosin light chain 2a antibodies that
do not label ARVM (Figure 3A). The label-
ing of telethonin showed a well-organized,
distinct sarcomeric pattern for the titin-
binding protein (Figure 3B). The immuno-
labeling for cardiac troponin-T and
vimentin confirmed, that vimentin is absent
from adult ventricular cardiomyocytes
(Figure 3C). The labeling of CARP showed
a distinct sarcomeric pattern (Figure 3D). In
fetal heart cardiomyocytes, all M-lines con-
tain embryonic-heart myomesin (EH-
myomesin), while this isoform is strongly
down-regulated after birth.29 On the other
hand, M-protein is a typical protein of the
adult M-line30 as was confirmed here in
ARVM (Figure 3E). EH-myomesin was
consistently found in all cultured hiPSC-
CMs (Figure 2 C,D), but not in freshly iso-
lated ARVM (Figure 3E). 
Quantification of immunolabeling
and sarcomeric organization
A manual quantification was performed
on populations of cells that showed either
incomplete sarcomeric organization as was
the case for telethonin (in 9.4% of all cells
organized in sarcomers) and CARP (orga-
nized in 32%), or showed a patchy distribu-
tion of expression such as observed for car-
diac troponin-I (found in 19% cells), alpha-
smooth muscle actin (in 23% cells), desmin
(in 9.9% cells), and the atrial/ventricular
light chain isoforms (72% MLC2v vs 25%
MLC2a) (Figure 4A). The quantitative
assessment of morphological features can
be instrumental to identify the maturation
stage of cardiomyocytes7 and therefore we
evaluated sarcomere length and the overall
shape of the cells in hiPSC-CMs compared
to ARVM. The analysis of sarcomere length
in cultured hiPSC-CMs compared to freshly
isolated ARVM showed a significant differ-
ence between the two cell types (Figure 4B)
with a value of 1.7±0.13 µm for hiPSC-
CMs and 1.9±0.09 for ARVM (n=40,
P<0.001). The form factor, i.e. the ratio of
cell length divided by the width, demon-
strates the extent of elongation (Figure 4C).
This parameter showed a significant differ-
ence between the cells, although there was a
considerable amount of variability
observed. The ratio was measured as
2.9±1.7 for hiPSC-CMs and 5.7±1.3 in
ARVM (n=17, P<0.001). 
Discussion
As iPSC-derived cells are growing in
popularity in recent years for both basic
research and drug development, there is a
need for a thorough characterization and
validation of these new tools. Still, ques-
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Figure 4 Quantification of immunolabeling and sarcomeric organization found only in a
fraction of the cell population, and sarcomere length and form factor in hiPSC-CMs versus
adult rat ventricular cardiomyocytes. A) Multiple optical fields from three independent
immunocytochemistry experiments were evaluated and results are displayed as parts of a
whole (total number of cells evaluated). Actin and vimentin were seen in all cells, while the
indicated smaller fraction showed additional proteins/features. B,C) The scatter plots show
mean and standard deviation, n=A40/B17 cells, ***P<0.001. B) Comparison of sarcomere
lengths in hiPSC-CM versus freshly isolated ARVM. C) Comparison of length-width ratio
(form factor) in cultured hiPSC-CM versus freshly isolated ARVM. 
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tions are raised about the general limitations
of iPSC-derived cardiomyocytes as com-
pared to more traditional models.31 In prin-
ciple, all investigations published so far on
the core properties of hiPSC-CMs have
found typical features of cardiac muscle.
The remaining issues are the immaturity of
the cells and the resulting differences in
gene expression when compared to the
adult human heart. Also, considerable het-
erogeneity between production lots and
within the cell population regarding car-
diomyocyte subtypes has been observed.2
For complex in vitro model systems with
multiple cell types or tissue-like 3D-culture
systems and tissue engineering approaches,
survival, stability, and development over
longer periods of time in culture are rele-
vant.14,32 These cytoskeleton markers and
the corresponding immunoreagents that we
have evaluated in this study provide effec-
tive tools for future investigations to assess
the maturation status of tissue constructs,
especially in the field of tissue engineering
where the integration of the tissue in a fully
developed host environment is crucial.
Although a variety of techniques for charac-
terizing hiPSC-CM has already been
employed so far, immunocytochemistry
provides a rapid and straightforward tool to
obtain information both on the protein
expression and differentiation level of cel-
lular features.
We have tested proteins that are either
known to become organized later in devel-
opment or represent associated proteins that
may serve as signaling or mechano-sensi-
tive elements. The intermediate filament
proteins desmin and vimentin are both
expressed in the embryonal and postnatal
heart, but only desmin remains as the char-
acteristic intermediate protein of both striat-
ed and smooth muscle in the adult.16 The
sarcomeric M-line protein myomesin serves
as a bona fide marker for myofibrils and
genuine cardiomyocytes in our experi-
ments, although by electron microscopy,
electron-dense M-lines as a further sign of
maturation have not yet been found in stan-
dard cultures of hiPSC-CMs.3 Regarding
the regulatory myosin light chain proteins it
has been reported, that almost all early
hiPSC-CM’s express MLC2a, and then at
later time-points, the MLC2v expressing
population becomes predominant, although
some cells still expressed or co-expressed
MLC2a13 (and personal observations). All
hiPSC-CMs were positive for cardiac tro-
ponin-T (cTnT) and the labeling was equal
in the entire cell population (not shown).
Regarding troponin-I, expression from the
fetal TNNI1 gene (ssTnI) is completely
replaced in the adult heart by TNNI3
(cTnI).33 In cultured hiPSC-CMs, cTnI
labeling demonstrated different levels in the
culture with some cells showing no labeling
at all, while others are strongly stained.
Similarly, CARP labeling showed a patchy
distribution, however with a distinctly visi-
ble sarcomeric structure in strongly
expressing cells. CARP is sensitive to car-
diotoxic cancer therapies and it is upregu-
lated in left ventricular heart failure,34 but it
is also normally expressed in cardiomy-
ocytes. Alpha smooth muscle actin (aSMA)
is expressed in the fetal and postnatal
heart.28 A different picture was observed in
telethonin-labeled cells. It has been pro-
posed that telethonin (T-cap) is important
for the maturation of sarcomeres, for sens-
ing biomechanical stress, and that its
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Figure 5. Developmentally regulated sarcomeric proteins. Overlay images including
DAPI are shown on the left, followed by corresponding green and red channel images in
greyscale. Images A and B were taken at higher magnification to resolve individual sar-
comers, while C and D show larger groups of cells, where labelled proteins appeared in
a sub-population of cells. A) Cells were immunostained for telethonin (green), all actin
(red), and DNA (blue); arrows point at foci of sarcomeric organization. B) Cells were
immunostained for CARP (green), all actin (red), and DNA (blue). C) Cells were
immunostained for cardiac troponin-I (green), all actin (red), and DNA (blue); the arrow
points at a cardiomyocyte negative for troponin-I. All actin labeled all the cells (C2). D)
Cells were immunostained for alpha-smooth muscle actin (green) and all actin (red); the
arrow points at a cardiomyocyte negative for alpha-smooth muscle actin and showing sar-
comeric striation in the actin channel; actin was observed in all cells (D2). 
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expression rapidly reacts to stimuli that lead
to muscular atrophy or growth.32,35
Although the signal was generally intense
in all hiPSC-CMs, a distinct sarcomeric pat-
tern was visible only in some places, sug-
gesting a robust expression of telethonin but
incomplete organization of the protein into
sarcomeres. These cytoskeleton proteins
discussed above may become instrumental
in the assessment of maturation in cardiac
in vitro models, since these proteins demon-
strate stages of a progression. Calcium han-
dling proteins such as the sodium-calcium
exchanger and ryanodine receptor have
been detected in hiPSC-CMs previously by
western blotting in our lab.14
Bin-1 is a membrane scaffolding  protein
in cardiomyocytes involved in the traffick-
ing of calcium-handling proteins to the T-
tubules via microtubules.21 Its localization
in an I band-associated pattern in the
hiPSC-CMs suggests that it is either form-
ing early T-tubules or a precursor protein
complex. Intercalated disc proteins in the
adult tissue are restricted to the ends of the
cylindrical cardiomyocytes.36 The pattern of
adherens and gap junctions as well as
desmosomes observed here in hiPSC-CMs
appeared similar compared to other culture
models of cultured cardiomyocytes.18 It is
therefore unlikely, that cell contact proteins
are the first choice for measuring matura-
tion of cardiomyocyte models unless the
geometry of the cells could be modified to
such extent that the strict polarization seen
in tissue reappears. In addition to immuno-
cytochemistry, additional methods such as
evaluation of morphological parameters,
protein biochemistry and gene expression
studies will complete the toolbox for the
development of improved in vitro models. 
In conclusion, all proteins that are known
to be expressed in primary cardiomyocytes
have been found in the hiPSC-CMs on day
10 in culture, identifying them as genuine
cardiomyocytes. However, the expression
pattern and patchy distribution of some pro-
teins suggest that the cell population is still
developing. A summary of the qualitative
assessment of expression and organization
of the investigated proteins is presented in
Table 2. 
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